Cigna Group $CI Shares Bought by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC grew its stake in Cigna Group (NYSE:CI) by 3.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 105,534 shares of the health services provider’s stock after buying an additional 3,814 shares during the period. Nisa Investment Advisors LLC’s holdings in Cigna Group were worth $29,046,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Harbor Capital Advisors Inc. increased its position in shares of Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares during the period. Beacon Financial Strategies CORP acquired a new stake in Cigna Group during the 4th quarter worth about $28,000. Collier Financial purchased a new stake in Cigna Group during the 3rd quarter valued at about $34,000. True Wealth Design LLC increased its holdings in shares of Cigna Group by 116.4% in the fourth quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock valued at $43,000 after purchasing an additional 85 shares during the period. Finally, Founders Capital Management increased its holdings in shares of Cigna Group by 53.0% in the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock valued at $44,000 after purchasing an additional 53 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts recently weighed in on CI shares. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Barclays dropped their price objective on shares of Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. Truist Financial increased their price objective on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research note on Tuesday, February 17th. Guggenheim reissued a “buy” rating and set a $318.00 target price on shares of Cigna Group in a report on Monday, February 2nd. Finally, Mizuho set a $325.00 target price on shares of Cigna Group in a research report on Friday, January 9th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $333.11.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the transaction, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. This trade represents a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is currently owned by insiders.

Cigna Group Stock Performance

NYSE CI opened at $266.54 on Wednesday. The stock has a market capitalization of $70.24 billion, a price-to-earnings ratio of 12.02, a PEG ratio of 0.89 and a beta of 0.27. The stock has a 50-day moving average of $276.72 and a 200 day moving average of $279.57. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.Cigna Group’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were issued a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Thursday, March 5th. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is presently 28.13%.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.